Case Study: a leading drug manufacturing company reduces data center footprint and migrates to cloud with HCL

HCL Helps A Leading Drug Manufacturer Adopt Cloud And Convert Capex To Opex

HCL partnered with a leading drug manufacturing company to address its need to consolidate data centers and migrate applications and workloads. The client was facing challenges with its rudimentary platforms, an internal private cloud, and a requirement to support R&D activities with a modern cloud infrastructure, aiming to convert capital expenditure to operational expenditure.

HCL implemented a comprehensive solution that significantly streamlined the client's infrastructure. This resulted in a reduction of servers from 5,000 to 3,500 and storage from 3.5PB to 2.5PB, while increasing the backup success rate to 95%. The vendor achieved a 40% reduction in data center footprint and successfully executed a factory migration for 1,800 out of 2,000 applications. The measurable impacts included a massive reduction in storage devices, a 1PB decrease in storage capacity, and significant performance improvements across the board, including a successful disaster recovery setup for key SAP environments.